Research Reference Only · Not Medical Advice · Not Intended For Human Use · Consult A Qualified Healthcare Professional
Back to protocols
Longevity Protocol · RR-P002

The Mitochondrial Protocol: SS-31, MOTS-C & Epitalon

Precisely sequenced three-compound protocol targeting cellular energy, metabolic signalling, and longevity pathways.

Research reference only. Research reference only. Not medical advice. Not intended for human use. Refrigerate all compounds after reconstitution.
Research reference only. Research reference only. Not medical advice. Not intended for human use.

Why Mitochondria?

Mitochondria are not simply power generators — they are signalling organelles that communicate with the nucleus, regulate inflammation, govern cell survival, and modulate metabolic rate systemically. Mitochondrial output declines with age: the electron transport chain becomes less efficient, ROS production increases, NAD+ levels fall, and cardiolipin degrades. This protocol addresses three different aspects of that decline through three compounds with distinct but complementary mechanisms.

Storage: All three compounds must be refrigerated after reconstitution. Room temperature storage after reconstitution degrades the compounds.

Reconstitution Reference

CompoundVial SizeBAC WaterDose Conversion
SS-31 (Elamipretide)10mg1ml10iu = 1mg
MOTS-C40mg2ml10iu = 2mg
Epitalon50mg2ml20iu = 5mg

Phase 1 — SS-31: Mitochondrial Foundation (Days 1-20)

SS-31 (Elamipretide) selectively concentrates in the inner mitochondrial membrane by binding to cardiolipin — a phospholipid unique to mitochondria. This allows it to quench ROS exactly at their production site, protecting electron transport chain complex integrity and improving ATP synthesis efficiency. Running SS-31 alone for 20 days builds the mitochondrial baseline before MOTS-C and Epitalon are layered in.

Phase 1 — SS-31Days 1-20 · Daily Morning
CompoundDoseTiming
SS-31 (Elamipretide)1mg (10iu)Daily — morning. Refrigerate after reconstitution.

Phase 2 — MOTS-C: Metabolic Activation (Day 21+)

MOTS-C is encoded within mitochondrial DNA itself — making it a true retrograde mitochondrial signal. It activates AMPK (the master cellular energy sensor), shifting metabolism toward fat oxidation, improving insulin sensitivity, and enhancing exercise capacity. Pre-workout timing maximises the metabolic demand intersection. From Day 41 dosing shifts to every other day as adaptation occurs.

Phase 2 — MOTS-CDay 21 Onward
PeriodDoseFrequency
Days 21-402mg (10iu)Daily — pre-workout
Day 41+2mg (10iu)Every other day

Phase 3 — Epitalon: The Longevity Layer (Days 31-50)

Epitalon is a synthetic tetrapeptide originally developed by Professor Vladimir Khavinson. Its primary mechanism is telomerase activation — the enzyme that maintains telomere length, which shortens with each cell division and is closely linked to cellular aging. It also regulates the pineal gland's melatonin production, relevant for circadian rhythm and sleep architecture. The protocol is exactly 20 days with a minimum 4-month rest — this is not a precaution, it is the documented protocol design.

Phase 3 — EpitalonDays 31-50 Only · Before Bed
CompoundDoseTimingDuration
Epitalon5mg (20iu)Daily — before bed20 days total. 2 × 50mg vials. Then 4+ months off.

Full Protocol Timeline

Day 1
SS-31 begins — 1mg daily, morning
Mitochondrial foundation phase. Only SS-31 running. Refrigerate after reconstitution.
Day 21
MOTS-C added — 2mg daily, pre-workout
Metabolic activation layer. SS-31 continues alongside.
Day 31
Epitalon added — 5mg nightly
All three compounds now running. Epitalon before bed, MOTS-C pre-workout, SS-31 morning.
Day 41
MOTS-C shifts to every other day
Metabolic adaptation means daily MOTS-C is no longer required.
Day 50
Epitalon complete — 4-month rest mandatory
20-day cycle done. Do not extend. Minimum 4 months rest before next cycle.

Do not extend Epitalon beyond 20 days. The 4-month rest is part of the protocol design, not a precaution. Running it continuously or longer is not supported by existing research literature.